Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax)

Laboratory Investigation

Volumn 76, Issue 1, 1997, Pages 77-87

  Lewis, William ^a   Griniuviene, Brone ^a   Tankersley, Kevin O ^a   Levine, Eric S ^a   Montione, Richard ^a   Engelman, Laura ^a   De Courten Myers, Gabrielle ^a   Ascenzi, Mary A ^b   Hornbuckle, William E ^b   Gerin, John L ^c   Tennant, Bud C ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIALURIDINE; MITOCHONDRIAL DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA DETERMINATION; DNA REPLICATION; MITOCHONDRIAL RESPIRATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WOODCHUCK;

ANIMALS; ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; DNA DAMAGE; DNA, MITOCHONDRIAL; HEART; HEPATITIS B; HEPATITIS B VIRUS, WOODCHUCK; KIDNEY; LIPIDS; LIVER; MARMOTA; MITOCHONDRIA; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MYOCARDIUM;

EID: 0031025313     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Anderson S, Bankier AT, Barrell BG, de Brujin MHL, Coulson AR, Brouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJH, Staden R, and Young IG (1981). Sequence and organization of the human mitochondrial genome. Nature 290:457-465.
2. Araki K, Miyazaki J-I, Hino O, Tomita N, Chisaka O, Matsubara K, and Yamamura K-I (1989). Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA 86:207-211.
3. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, and Schoen EA (1991). Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337:508-510.
4. Blin N and Strafford DW (1976). A general method for isolation of high molecular weight DNA from eucaryotes. Nucleic Acids Res 3:2303-2308.
5. Blum HE, Stowring L, Figus A, Montgomery CK, Haase AT, and Vyas GN (1983). Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci USA 80:6685-6688.
6. Chen C-H, Vazquez-Padua M, and Cheng Y-C (1991). Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implications for delayed toxicity. Mol Pharmacol 39:625-628.
7. Cui L, Yoon S, Schinazi RF, and Sommadossi J-P (1995). Cellular and molecular events leading to mitochondrial toxicity of 1-[2′-deoxy-2′-fluoro-β-D-arabinofuranosyl]-5-iodouracil in human liver cells. J Clin Invest 95:555-563.
8. Dalakas MC, Illa I, Pezeshkpour G, Laukaitis J, Cohen J, and Griffin J (1990). Mitochondrial myopathy caused by long term zidovudine therapy. N Engl J Med 322:1098-1105.
9. Eriksson S, Xu B, and Clayton DA (1995). Efficient incorporation of anti-HIV deoxynucleotides by recombinant yeast mitochondrial DNA polymerase. J Biol Chem 270:18929-18934.
10. Freiman JP, Helfert KE, Hamrell MR, and Stein DS (1993). Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 7:379-385.
11. Fromenty B and Pessayre D (1995). Inhibition of mitochondrial β-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67:101-154.
12. Kaguni LS, Wernette CM, Conway MC, and Yang-Cashman P (1988). Structural and catalytic features of the mitochondrial DNA polymerase from Drosophila melanogaster embryos. Cancer Cells 6:425-432.
13. Lamperth L, Dalakas MC, Dagani F, Anderson J, and Ferrari R (1991). Abnormal skeletal and cardiac mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest 65:742-751.
14. Lewis W, Chomyn A, Gonzalez B, and Papoian T (1992). Zidovudine induces molecular, biochemical and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 89:1354-1360.
15. Lewis W and Dalakas MC (1995). Delayed mitochondrial toxicity of antiviral nucleoside analogs. Nat Med 1:417-422.
16. Lewis W and Gonzalez B (1990). Actin isoform mRNA alterations induced by doxorubicin in cultured heart cells. Lab Invest 62:69-76.
17. Lewis W, Levine ES, Griniuviene B, Tankersley KO, Sommadossi J-P, Watanabe K, Colacino J, and Perrino FW (1996). Fialuridine and its metabolites inhibit DNA polymerase-γ at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci USA 93:3592-3597.
18. Lewis W, Meyer RR, Simpson JF, Colacino JM, and Perrino FW (1994b). Mammalian DNA polymerases α, β, γ, δ, and ε incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU triphosphate. Biochemistry 33:14620-14624.
19. Lewis W, Papoian T, Gonzalez B, Louie H, Kelly DP, Payne RM, and Grody WW (1991). Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest 65:228-236.
20. Lewis W and Perrino FW (1996). Mitochondrial toxicity of FIAU. N Engl J Med 334:1136.
21. Lewis W, Simpson JF, and Meyer RR (1994a). Cardiac mitochondrial DNA polymerase-γ is inhibited competitively and non-competitively by phosphorylated zidovudine. Circ Res 74:344-348.
22. MacIlwain C (1994). US health agencies at odds over trial deaths. Nature 369:433.
23. Maniatis T, Fritsch EF, and Sambrook J (1982). In: Irwin N, editor. Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory, 545.
24. Marshall E (1994). Drug trial deaths deemed unavoidable. Science 264:1530.
25. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie A, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, and Hoofnagle JH (1995). Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333:1099-1105.
26. Nagashima H, Imai M, and Iwakura Y (1993). Aberrant tissue specific expression of the transgene in transgenic mice that carry the hepatitis B virus genome defective in the X gene. Arch Virol 132:381-397.
27. Popper H, Roth L, Purcell RH, Tennant BC, and Gerin JL (1987). Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 84:866-870.
28. Richardson FC, Engelhart JA, and Bowsher RR (1994). Fialuridine accumulates in the DNA of dogs, monkeys, and rats following long-term oral administration. Proc Natl Acad Sci USA 91:12003-12007.
29. Semino-Mora MC, Leon-Monzon ME, and Dalakas MC (1994). Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Lab Invest 71:102-112.
30. Simpson MV, Chin CD, Keilbaugh SA, Lin TS, and Prusoff WH (1989). Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine. Biochem Pharmacol 38:1033-1036.
31. Swartz MN (1995). Mitochondrial toxicity: New adverse drug effects. N Engl J Med 333:1146-1148.
32. Tennant BC and Gerin JL (1994). The woodchuck model of hepatitis B virus infection. In: Arias IM, Boyer J, Fausto N, Jakoby WB, Schachter D, and Shafritz DA, editors. The liver: Biology and pathobiology, 3rd ed. New York: Raven Press.
33. Wahl GM, Stern M, and Stark GM (1979). Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci USA 76:3683-3687.
34. Wallace DC (1992). Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212.